methotrexate has been researched along with Hypercholesterolemia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, C; Fiore, S; Fleischmann, R; Garg, A; Genovese, MC; Graham, NM; Huizinga, TW; Kivitz, AJ; Martincova, R; Rell-Bakalarska, M; Rohane, P; Stahl, N; van Adelsberg, J; van der Heijde, D; van Hoogstraten, H; Weinstein, SP; Yancopoulos, GD | 1 |
Agular, B; Gröndal, G; Hansen, I; Jensen, EC; Johansen, P; Juul, L; Lindegaard, HM; Schlemmer, AM | 1 |
Burmester, GR; Camp, HS; Genovese, MC; Jungerwirth, S; Khan, N; Meerwein, S; Othman, AA; Pangan, AL; Smolen, JS; Wang, L; Weinblatt, ME | 1 |
Cabanillas, M; de las Heras, C; León-Mateos, A; Monteagudo, B; Pérez-Valcárcel, J; Suárez-Amor, O | 1 |
Beg, S; Lopez-Olivo, MA; Singh, JA | 1 |
Blanco Alonso, R; Rueda Gotor, J | 1 |
Berg, CL; Gollan, JL | 1 |
4 review(s) available for methotrexate and Hypercholesterolemia
Article | Year |
---|---|
[Down syndrome: another cause of immunosuppression associated with multiple eruptive dermatofibromas?].
Topics: Adult; Arthritis, Psoriatic; Down Syndrome; Female; Graves Disease; Histiocytoma, Benign Fibrous; Humans; Hypercholesterolemia; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Middle Aged; Neoplasms, Multiple Primary; Skin Neoplasms | 2009 |
Tocilizumab for rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Hypercholesterolemia; Methotrexate; Randomized Controlled Trials as Topic | 2010 |
[Tocilizumab in rheumatoid arthritis].
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Disease Susceptibility; Drug Therapy, Combination; Humans; Hypercholesterolemia; Infections; Methotrexate; Multicenter Studies as Topic; Receptors, Interleukin-6 | 2011 |
Primary biliary cirrhosis: new therapeutic directions.
Topics: Bone Diseases, Metabolic; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Liver Transplantation; Methotrexate; Pruritus; Ursodeoxycholic Acid | 1992 |
3 trial(s) available for methotrexate and Hypercholesterolemia
Article | Year |
---|---|
Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Interleukin-6 Receptor alpha Subunit; Male; Methotrexate; Middle Aged; Neutropenia; Treatment Outcome; Young Adult | 2015 |
Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Drug Hypersensitivity; Edema; Fatigue; Female; Flushing; Glucocorticoids; Headache; Humans; Hypercholesterolemia; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Nasopharyngitis; Neutropenia; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Hemoglobins; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Hypercholesterolemia; Janus Kinase 1; Male; Methotrexate; Middle Aged; Pharyngitis; Protein Kinase Inhibitors; Treatment Outcome | 2016 |